The FDA announced today that it is allowing undiluted, frozen vials of the Pfizer-BioNTech COVID-19 vaccine to be transported and stored for up to two weeks at conventional temperatures commonly found in pharmaceutical freezers.
The decision should allow for wider distribution of the vaccine to sites that do not have ultra-low temperature freezers.
Get the full story on our sister site, Medical Design & Outsourcing.